Laurent Chouchana 1,∗, Laure-Hélène Preta 1, Mylène Tisseyre 1, et. al., PMCID: PMC7907730 PMID: 33647327 Remdesivir is a novel adenosine-like nucleotide analogue, representing the first drug approved for coronavirus disease 2019 (COVID-19), albeit an uncertain clinical relevance. In…[...]
Read More
This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person…[...]
Read More
Five years into the COVID-19 pandemic, long-haul symptoms continue to affect millions—and the kidneys are emerging as one of the most vulnerable organs in this prolonged aftermath. While much attention…[...]
Read More
Emerging 2025 research reveals a compelling link between Long COVID and urinary tract infections (UTIs), with implications for kidney damage, bladder dysfunction, and chronic urinary symptoms. This article synthesizes findings…[...]
Read More
Viyaasan Mahalingasivam, MPhil1,2,3; Anne-Laure Faucon, MD, PhD2,4; et.al. JAMA Netw Open. 2024;7(12):e2450014. doi:10.1001/jamanetworkopen.2024.50014 Key Points Question Is there an acceleration in kidney function decline after COVID-19 infection and does it differ from after other lung infections? Findings In this…[...]
Read More
By Mary Kekatos RFK Jr. cuts COVID-19 vaccine recommendation for healthy kids, pregnant womenHHS Secretary Robert F. Kennedy Jr. has announced the department will no longer recommend the COVID-19 vaccine…[...]
Read More
This installment of the RECOVER Research Update—a summary of recent findings published every 3 months—focuses on innovative research using patient information contained in electronic health records (EHRs). Each time a person…[...]
Read More
Yukako Umezawa • Hitoshi Suzuki • Hitomi Hirose • et.al. DOI: 10.7759/cureus.81085 Abstract Background Although the coronavirus disease 2019 (COVID-19) vaccine has been shown to be effective in preventing severe COVID-19 infection, many vaccine-related adverse events have…[...]
Read More
by J.M. Phelps Gateway Pundit Using data from the Department of Defense (DOD) Joint Trauma System (JTS), The Remdesivir Papers came to life on October 4, 2024. In the 5,400-word report by J.M. Phelps…[...]
Read More
Lun-Wu Hung • Mei-Yuan Liu • Tsung Yu • et. al. Abstract Background Previous studies have suggested that zinc deficiency (ZD) may increase the risk of short-term mortality in patients with coronavirus disease 2019 (COVID-19). However,…[...]
Read More